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LETTERS TO THE EDITOR
 
ARE BLOOD DONORS AN 
ADEQUATE CONTROL GROUP TO 
ASCERTAIN HCV PREVALENCE IN 
NON-HODGKIN’S LYMPHOMA 
PATIENTS
 
To the Editor,
 
We have read with interest the paper of Kuniyoshi 
 
et al.
 
on hepatitis B or C infections and non-Hodgkin’s lym-
phoma (NHL) recently published in the Journal.
 
1
 
Of the 348 patients with NHL, 8.1% of cases were
hepatitis C virus (HCV) positive and 6.9% were hepa-
titis B virus (HBV) positive. In male NHL patients, the
rate of HCV infection was significantly higher than in an
age- and sex-matched population of blood donors in the
same area.
 
1
 
Consequently, the authors concluded that the high
prevalence of HCV or HBV infection in the study pop-
ulation provides epidemiologic evidence that HCV and
HBV infection may be involved in the development of a
subgroup of NHL in males.
We would like to focus on the HCV prevalence rate
data because this is a critical issue and to clarify the
existing relationship between HCV infection and NHL.
In fact, the epidemiologic studies conducted so far
are rather contradictory: studies conducted in southern
Europe have reported a high prevalence (9–37%) of
HCV infection in patients with B cell NHL, whereas
those performed in western Europe and in Canada have
failed to confirm this association.
 
2
 
Whether these controversial data reflect virologic dif-
ferences in genotypes and/or ethnogeographic dispari-
ties or weakness in the statistical power of the studies
remains a matter of debate.
We would like to draw your attention to the possibility
that an inadequate choice of control population may
represent a serious bias.
The study of Kuniyoshi 
 
et al.
 
 has been performed on
NHL patients diagnosed in the district of Fukuoka.
 
1
 
 A
previously published prevalence study on the general
population conducted in the same geographic district
reported a 2% prevalence rate of HCV infection among
14 341 subjects, with a definite age prevalence curve:
 
3
 
HCV infection rate ranged from 0.4% in the under-29
age group to 12% in the over-70 age group.
In the paper of Kuniyoshi 
 
et al.
 
,
 
1
 
 the blood donor
control group showed only a 0.75% crude prevalence
rate with a much lower increase in HCV infection rate
with age (higher value 1.99% in the 50–64 years age
group) and ignores individuals in the over 65 age group,
an age group to which more than 45% of the NHL
patients belong.
It is well known that the prevalence of HCV infection
among subjects representative of the entire population
is higher than that found among blood donors.
 
4
 
 By
using age-specific prevalence data, at least three distinct
transmission patterns can be identified. In countries
such as Japan or Italy, most infections are found among
older people, a fact that is consistent with the risk
for HCV infection being greater in the distant past.
 
5
 
Seventy-five percent of NHL patients in the report of
Kuniyoshi 
 
et al.
 
1
 
 are older than 50 years and all HCV-
positive NHL patients fell into this group, a picture
very similar to that reported by Hayashi 
 
et al.
 
3
 
 in the
general population. If the comparison had been made
with the latter control group, no significant differences
would have been found between controls and the study
population.
Non-Hodgkin’s lymphomas are diseases of the eld-
erly; therefore, it should be taken into account that a
cohort effect could have been highlighted in the study of
Kunyioshi 
 
et al.
 
 The higher prevalence of HCV infection
found by Kuniyoshi 
 
et al.
 
 in male NHL is intriguing and
not easy to explain. It cannot be ruled out that HCV can
play a role in the development of a selected type of
NHL.
 
6
 
 However, we think that this issue needs to be
addressed with a well-designed prospective study on a
Poisson study cohort and a properly chosen control
population, which must be truly representative of HCV
prevalence in the general population.
Moreover, people with cancer are often referred to
highly specialized centers far away from where the live.
As a consequence of the wide variations of HCV prev-
alence rate in different geographic areas,
 
4,5
 
 even within
the same country, the place of birth, as well as resi-
dence, of affected people rather than the hospital where
NHL has been diagnosed should be considered.
In conclusion, we believe that the choice of blood
donors as a control group, as well as the comparison of
non-age-adjusted prevalence rates are crucial biases that
may explain, at least in part, the conflicting results on
HCV prevalence in NHL in studies performed in coun-
tries with high HCV infection rate.
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A CASE OF HEMOLYTIC UREMIC 
SYNDROME AND WHOLE SPLENIC 
INFARCTION SECONDARY TO 
ACUTE PANCREATITIS
 
To the Editor,
 
Hemolytic uremic syndrome (HUS) and whole splenic
infarction are relatively rare complications of acute pan-
creatitis. Herein, we report on a 58-year-old Japanese
man with acute pancreatitis complicated with both
manifestations. To our knowledge, such a case has not
been reported previously.
The patient was admitted to Sumitomo Hospital
complaining of severe epigastric pain after drinking
alcohol on 7 September 2001. He had been a heavy
alcohol drinker for more than 30 years. His past history
was unremarkable. His consciousness was clear and his
temperature was 38.5
 
°
 
C. Physical examination revealed
only epigastric tenderness. Laboratory data were as
follows: hemoglobin (Hb) 15.5 g/dL, white blood cell
(WBC) 10 100 /
 
µ
 
L, platelets 145 000 /
 
µ
 
L, amylase
1313 U/L, bilirubin 1.0 mg/dL, lactate dehydrogenase
(LDH) 896 U/L and creatinine 1.0 g/dL. Liver enzymes
were slightly elevated. Abdominal ultrasound and
computed tomography (CT) showed swelling of the
pancreas and fluid accumulation in the anterior para-
pancreatic space (Fig. 1a). A diagnosis of acute pancre-
atitis was made and the usual treatment initiated. On
the third day, the abdominal pain gradually subsided
and the serum amylase level decreased to 824 U/L,
while the patient was icteric and acute renal failure
developed. The Hb was 8.3 g/dL, WBC count 9600 /
 
µ
 
L,
platelet count 14 000 /
 
µ
 
L, LDH 1701 U/L, bilirubin
5.7 mg/dL, creatinine 3.2 g/dL and the blood film was
typical of microangiopathic hemolytic anemia, showing
the presence of fragmented red blood cells. The serum
haptoglobin level decreased to 29 mg/dL (normal 45–
320 mg/dL). The prothrombin time (PT) was normal,
the international normalized ratio (INR) was 0.92, the
partial thromboplastine time (PTT) was 33.6/33.2 s,
fibrinogen was 599 mg/dL and the concentration of
fibrinogen degradation products (FDP) and the 
 
D
 
-
dimer test were at the upper limits of normal. We
 
Figure 1
 
(a) Abdominal computed tomography (CT) of the
patient on admission revealed swelling of the pancreas and
fluid accumulation in the anterior parapancreatic space. (b)
Abdominal enhanced CT on the 29th day. The spleen was not
enhanced in the least (arrow), which showed whole splenic
infarction. (c) Abdominal enhanced CT on the 57th day
showed a quite atrophic spleen (arrow) that could not be dif-
ferentiated from the stomach.
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believed that the patient was suffering from HUS and
fresh frozen plasma (total 16 units) was given and a
hemodialysis program was started. After this, the Hb
slowly rose, the fragmented red cells decreased and
the platelet counts were normalized on the 9th day.
The serum creatinine level was elevated to 6.2 mg/dL
on the 11th day, from which time renal function
improved and recovered to within the normal range on
the 26th day.
On the 29th day, while the patient recovered from the
pancreatitis and HUS, he complained of sudden left
upper quadrant pain. Abdominal enhanced CT
revealed whole splenic infarction (Fig. 1b). Two days
after onset, his temperature rose to 38.8
 
°
 
C. Conserva-
tive management, including administration of antibiot-
ics, was initiated and the pain and fever subsided. No
complications, such as active bleeding or abscess for-
mation, were found. Although a follow-up abdominal
CT at 4 weeks after onset revealed a quite atrophic
spleen that could not be differentiated from the stomach
(Fig. 1c), the patient was asymptomatic and discharged.
Hemolytic uremic syndrome is a rare complication of
acute pancreatitis. Although solitary, multiple or mas-
sive splenic infarction is sometimes found in patients
with pancreatitis, whole infarction is relatively rare. We
have reported a case of acute pancreatitis accompanied
by both rare manifestations. In a review of English lit-
erature, such a case has not been reported previously.
Disseminated intravascular coagulation (DIC) is a
common complication of acute pancreatitis. Patients
with severe DIC reveal marked thrombocytopenia, ane-
mia and variable renal involvement, as found in the
present case, while these patients are always expected to
have prolonged PT and/or PTT. However, in the
present case, from the results of normal PT, PTT, FDP
and 
 
D
 
-dimer test, we diagnosed the patient as suffering
from HUS although a renal biopsy was not performed.
Pathophysiologic mechanisms of HUS secondary to
acute pancreatitis are not clearly established. A variety
of proteases and cytokines, such as interleukin-1 and
tumor necrosis factor-
 
α
 
, released during acute pancre-
atitis can directly and/or indirectly damage the endot-
helium and promote platelet aggregation, which may
lead to HUS. The apparent reversibility of renal insuf-
ficiency following treatment with plasmapheresis, fresh
frozen plasma infusions and hemodialysis has often
been reported in patients with HUS secondary to acute
pancreatitis.
 
1–3
 
 In the present case, the renal function of
the patient recovered to normal within 24 days after
starting treatment for HUS. The reason for the revers-
ibility is unclear because renal biopsies have not been
performed in most cases, including the present case.
One possible explanation is that the pathology involving
the kidneys may be glomerular rather than the more
severe arteriolar-type thrombotic microangiopathy in
many cases of HUS secondary to pancreatitis, which
may lead to a good prognosis.
 
4
 
Splenic infarction is seen in 5–7% of cases of acute
pancreatitis and is usually of the partial type. Rypens 
 
et
al
 
.
 
5
 
 reported that whole infarction was not found in 14
cases of splenic infarction secondary to acute pancre-
atitis. In addition, most cases of splenic infarction have
been reported to heal spontaneously and primary con-
servative management may be proposed.
 
5
 
 In the present
case, conservative treatment was initiated and led to a
good outcome because the patient had a stable hemo-
dynamic condition.
In the present case, an association between HUS and
whole splenic infarction is unclear. Two possible expla-
nations can be given. One is that the two complications
may have occurred independently. It has been reported
that thrombus and dissection of pseudocyst may cause
splenic infarction. On the basis of no evidence of pan-
creatic pseudocyst in our patient, whole splenic infarc-
tion may have been caused by the complete obstruction
of the splenic artery by a thrombus due to intrinsic
damage to the vessel intima after inflammation. The
other possible explanation is that the thrombus raised
on the basis of HUS may have completely obliterated
the splenic artery, resulting in whole splenic infarction.
We favor the former explanation because the infarction
occurred after the patient had recovered completely
from HUS and because no clinical signs of a thrombus
were found in any other organs.
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